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Abstract
Retinitis pigmentosa (RP) is a degenerative disease leading to photoreceptor cell loss.
Mouse models of RP, such as the rd10 mouse (B6.CXBl-Pde6brd10/J), have enhanced our
understanding of the disease, allowing for development of potential therapeutics. In 2011,
our group first demonstrated that the synthetic progesterone analogue ‘Norgestrel’ is neu-
roprotective in two mouse models of retinal degeneration, including the rd10 mouse. We
have since elucidated several mechanisms by which Norgestrel protects stressed photore-
ceptors, such as upregulating growth factors. This study consequently aimed to further
characterize Norgestrel’s neuroprotective effects. Specifically, we sought to investigate the
role that microglia might play; for microglial-derived inflammation has been shown to poten-
tiate neurodegeneration. Dams of post-natal day (P) 10 rd10 pups were given a Norgestrel-
supplemented diet (80mg/kg). Upon weaning, pups remained on Norgestrel. Tissue was
harvested from P15-P50 rd10 mice on control or Norgestrel-supplemented diet. Norgestrel-
diet administration provided significant retinal protection out to P40 in rd10 mice. Alterations
in microglial activity coincided with significant protection, implicating microglial changes in
Norgestrel-induced neuroprotection. Utilizing primary cultures of retinal microglia and
661W photoreceptor-like cells, we show that rd10 microglia drive neuronal cell death. We
reveal a novel role of Norgestrel, acting directly on microglia to reduce pro-inflammatory
activation and prevent neuronal cell death. Norgestrel effectively suppresses cytokine, che-
mokine and danger-associated molecular pattern molecule (DAMP) expression in the rd10
retina. Remarkably, Norgestrel upregulates fractalkine-CX3CR1 signaling 1 000-fold at the
RNA level, in the rd10 mouse. Fractalkine-CX3CR1 signaling has been shown to protect
neurons by regulating retinal microglial activation and migration. Ultimately, these results
present Norgestrel as a promising treatment for RP, with dual actions as a neuroprotective
and anti-inflammatory agent in the retina.
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Introduction
Retinitis pigmentosa (RP) encompasses a set of hereditary diseases resulting in a progressive
loss of rod and subsequently cone photoreceptors, leading to eventual blindness [1]. The rd10
mouse model of RP possesses a mutation in the phosphodiesterase-6b (pde6b) gene [2–4]. A
suitable model for studying cell death in RP, the course of photoreceptor cell loss and subse-
quent retinal degeneration in this mouse closely resembles disease progression in humans [5–
9]. In 2011, our group showed that the synthetic progestin ‘Norgestrel’ works as a neuroprotec-
tive agent in the retina, thus identifying it as a potential treatment for RP [10]. Published stud-
ies have since shown that Norgestrel, working through progesterone receptors [11],
significantly increases production of basic fibroblast growth factor (bFGF) and leukemia inhib-
itory factor (LIF) in the retina [10, 12]. These growth factors likely act directly on photorecep-
tors to provide neuroprotection, through an upregulation of pro-survival and downregulation
of apoptotic pathways [13].
We are beginning to understandmore about the mechanism of action of Norgestrel on pho-
toreceptors. However, the effect of Norgestrel on other cell types in the retina has yet to be
studied in detail. Particularly, can Norgestrel work on the resident retinal macrophages, the
microglia?Macrophages are essential in the clearance of cell debris, maintaining homeostasis
and facilitating tissue repair following injury in the central nervous system [14–16]. However,
macrophages have also been implicated in the pathology of many neurodegenerative diseases,
in which neuroinflammation is considered to be a hallmark [17]. Previous studies have
highlighted a detrimental role for microglia as drivers of retinal cell degeneration [18–21]. In
the rd10 mouse, microglia respond to the mutation as early as P5 and are found in close associ-
ation with the photoreceptors during the period of initial cell loss [9]. Other studies have
shown that whenmicroglial cells are either genetically ablated, their phagocytic ability inhib-
ited [18], or their pro-inflammatory activities dampened by anti-inflammatory drug adminis-
tration [19], disease progression is attenuated in the rd10 retina.
The aim of this study was to develop our understanding of how Norgestrel works to provide
neuroprotection in a mouse model of RP, with a particular focus on the response of retinal
microglia to Norgestrel, if any. Interestingly, neurosteroid signaling has previously been shown
to dampen damaging inflammatory gene expression [22–25]. We examined interactions
between rd10 retinal microglia and the 661W photoreceptor-like cell line in vitro and show
that microglial-driven 661W cell death is abrogated by pre-treating microglia with Norgestrel.
This result highlights a novel role for Norgestrel as an anti-inflammatory agent, working
directly on microglia to reduce their pro-inflammatory phenotype and consequentially pro-
mote survival of photoreceptors. We also provide evidence for Norgestrel upregulating the
neuroprotective compound fractalkine in the rd10 retina, which could further dampen micro-
glial activity. In support of this hypothesis, treatment of primary rd10 microglia with recombi-
nant fractalkine reduces their ability to kill 661W cells. Future studies will be aimed at further
investigating the role that fractalkineplays in Norgestrel’s neuroprotective effects.
Materials and Methods
Mice
All animals were handled and maintained following the Association for Research in Vision and
Ophthalmology statement for the Use of Animals in Ophthalmic and Vision Research (License
Number AE19130/P009). Experiments were approved by University College Cork Animal
Experimentation Ethics Committee and were performed using both male and female homozy-
gous rd10/rd10 mice (B6.CXBI-Pde6brd10/J) and C57 mice (C57BL/6J).Mice were supplied by
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the Biological ServicesUnit, University College Cork and were humanely euthanized by cervi-
cal dislocation.
Norgestrel-supplemented diet
Norgestrel-supplemented and control diets were manufactured by Testdiet (Middlesex, UK).
Norgestrel was added to the chow at a concentration of 0.05% (500ppm). Dams of rd10 pups
were given a Norgestrel-supplemented diet (LabDiet 5053, custom diet containing D (-) Nor-
gestrel (N2260) (Sigma Aldrich,Missouri, US) when the pups were P10 to allow pups to receive
Norgestrel in the milk. This equates to a daily intake of approximately 80mg/kg, assuming a
30g mouse consumes around 5g of food/day. Specializeddiet soaked in water was also added to
the cage in order for pups to receive Norgestrel directly, as soon as they began to eat. These
pups were also given Norgestrel-supplemented diet post-weaning.With control litters, diet
changes were replicated with a control diet (LabDiet 5053 control diet). Dams were given regu-
lar chow once pups were weaned.
Immunohistochemistry on retinal sections
Eyes were enucleated and fixed at room temperature in 4% paraformaldehyde (PFA) for 1.5 h.
Following washes, eyes were cryo-protected in 15% sucrose in 1xPBS for 1 h, 20% sucrose for 1.5
h and 30% sucrose overnight, all at 4°C. Eyes were submerged and frozen in cryochrome
(Thermo Scientific,Waltham, US) and sectionedon a cryostat (Leica,Wetzlar, Germany). Sec-
tions (7μm) were collected on Superfrost glass slides (Fisher Scientific,Waltham, US) and stored
at -80°C. Sectionswere blocked and permeabilizedwith 0.1% Triton X and 5% donkey serum in
1xPBS for 30 min and incubated with primary antibody diluted in 5% donkey serumovernight at
4°C. Table 1 lists the details of all primary antibodies used. Following washes, sectionswere incu-
bated with secondary antibody (Alexa Fluor donkey anti-mouse/rabbit/goat with either a 488 or
594 fluorescent probe; Molecular Probes &/or FITC–PNA (Vector Labs, Burlingame, US.)) with
the nuclear stain, Hoechst (Thermo Scientific) for 1 h at room temperature. Eliminating the pri-
mary antibody in solution served as a negative control. Sectionswere mounted usingMowiol
(Sigma) with anti-fade agent Dabco (Sigma). Images were taken from central and peripheral
regions of the retina. Regions identified as central and peripheral are shown in S1 Fig.
Immunohistochemistry on cells
Microglia and 661W cells cultured on polylysine-coated coverslips in 24 well plates were fixed
with 4% PFA for 10 min at room temperature. Cells were blocked and permeabilized in 0.1%
Triton X and 5% donkey serum in 1xPBS for 10 min and incubated with primary antibody
diluted in 5% donkey serum overnight at 4°C. Table 1 lists the details of all primary antibodies
used. Following washes, coverslips were incubated with secondary antibody (Alexa Fluor don-
key anti-mouse/rabbit/goat with either a 488 or 594 fluorescent probe) with the nuclear stain,
Hoechst (Thermo Scientific) for 1 h at room temperature. Eliminating the primary antibody in
solution served as a negative control. Coverslips were mounted on to glass slides using Mowiol.
Microscopy
Retinal sections and cell preparations were viewed using a Leica DM LB2 microscopewith
Nikon Digital Sight DS-U2 camera, using 10x, 40x and 100x objectives. Images were taken
using the software NIS-Elements version 3.0, Nikon, Japan. Immunofluorescence on retinal
sections was performed on at least three mice of each group, at each time-point. Immunofluo-
rescence on cell preparations was also performed in triplicate. Confocalmicrographs were
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taken using an Olympus Fluoview FV1000 laser scanning confocal microscope, using 20x and
60x objectives. Images were taken using the software Olympus Fluoview Ver 4.1a and are rep-
resented as single slices in the XY plane or maximum intensity projections from acquisition of
z-stacks. Identical microscope settings were used when visualizing specificmarkers across all
timepoints and treatments.
Terminal dUTP nick-end labeling (TUNEL) of fragmented DNA
DNA strand breaks in retinal cell nuclei and 661W cells were detected by terminal dUTP nick-
end labeling (TUNEL) on fixed tissue and cells. Frozen retinal sections or coverslips with cells
were permeabilzedwith 0.1% Triton X for 2 min followed by incubation with terminal deoxy-
nucleotidyl transferase (Promega, Wisconsin, US) and fluorescein-12-dUTP (Roche, Risch-
Rotkreuz, Switzerland) according to manufacturer’s instructions.Nuclei were counterstained
with Hoechst 33342 (1μg/mL) (Sigma). Sections and cells were incubated at 37°C for 1 h in a
humidified chamber and following several washes in 1xPBS, were mounted inMowiol. Sections
were viewed under a fluorescencemicroscope (Leica DM LB2). In co-culture assays, TUNEL-
positive 661W cells could easily be distinguished frommicroglia based on nuclear size and
phase contrast of cell preparations. For each treatment on mice, at least three animals were
used and three fields (x40 magnification) per section of at least three different sections were
evaluated. For each treatment on coverslips, 6 coverslips were used per treatment and 50–200
661W cells analyzed per coverslip for TUNEL positivity.
ERG recordings
Dark-adapted (12 h) mice were anaesthetizedwith an intraperitoneal injection of ketamine
(100 mg/kg)—xylazine (4 mg/kg) and maintained on a thermal blanket at 38°C for the entire
Table 1. List of antibodies and lectins used in western blotting and immunofluorescence.
Antibody/Lectin Supplier Catalogue # Host Dilution Factor
Rhodopsin Millipore AB9279 Rabbit poly IF 1:200
FITC-PNA Vector Labs FL-1071 - IF 1:500
Iba1 Wako 019–19741 Rabbit poly IF 1:500
Iba1 Novus Bio NB100-1028 Goat poly IF 1:400
CD68 AbD Serotec MCA1957GA Rat mono IF 1:500
iNos Cell Signalling 13120 Rabbit mono IF 1:200
MRC1 Abcam AB64693 Rabbit poly IF 1:1000
Cone Arrestin Millipore AB15282 Rabbit poly IF 1:1000
PR A/B Abcam AB2764 Mouse mono IF 1:100
PGRMC1 Sigma HPA002877 Rabbit poly IF 1:100
PGRMC2 Santa Cruz sc-104609 Goat poly IF 1:200
mPRα Santa Cruz sc-50111 Goat poly IF 1:100
mPRβ Abcam ab46534 Rabbit poly IF 1:100
mPRγ Abcam ab79517 Rabbit poly IF 1:100
GFAP Sigma G3893 Mouse mono IF 1:300
Glutamine Syn. Millipore MAB302 Mouse mono IF 1:100
NFM Abcam ab7794 Mouse mono IF 1:500
Syntaxin 1 Millipore AB5820 Rabbit poly IF 1:500
Calbindin Swant CB-38a Rabbit mono IF 1:500
CHX10 Santa Cruz sc-21690 Goat poly IF 1:100
Fractalkine Abcam ab25088 Rabbit poly IF 1:1000 WB 1:1000
doi:10.1371/journal.pone.0165197.t001
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procedure. 1% tropicamide (Alcon Cusí, Barcelona, Spain) was applied topically on the eyes to
dilate the pupils and viscotears (Novartis, Barcelona, Spain) was instilled on the corneas to pre-
vent dehydration and optimize contact with the recording electrodes (DTL fiber with an
X-Static silver-coated nylon conductive strand; Sauquoit Industries, Scranton, PA). The refer-
ence electrodewas a 25-gauge platinum needle inserted under the scalp and a gold electrode,
located in the mouth, acted as ground. Animal handling and preparation was done under dim
red light and the mice were placed on a Faraday cage where all the recordings were performed
in total darkness. Scotopic flash-inducedERG responses were recorded simultaneously from
both eyes in response to light stimuli produced with a Ganzfeld illuminator. Light stimuli of 10
ms of duration were presented at 11 different increasing luminances, ranging from −5.2 to 0
log cd s/m2. Three to ten consecutive recordings were averaged for each light presentation. The
interval between stimuli was 10 s for dim flashes (−5.2 to −1.4 log cd s/m2) and up to 20 s for
the highest luminance’s (−0.8 to 0 log cd s/m2). ERG signals were amplified and band-pass fil-
tered (1–1000 Hz, without notch filtering) using a DAM50 data acquisition board (World Pre-
cision Instruments, Aston, UK). Stimuli presentation and data acquisition (4 kHz) were
performed using a PowerLab system (AD Instruments, Oxfordshire, UK). Recordings were
analyzed off-line. The amplitude of the a-wave was measured from the baseline and the ampli-
tude of the b-wave was measured from the trough of the a-wave to the peak of the b-wave.
Culture of cell lines
Experiments were carried out using the mouse 661W cone photoreceptor-derived cell line,
generously provided by Dr Muayyad Al-Ubaidi (Department of Cell Biology, University of
Oklahoma, Health Sciences Centre, Oklahoma City, OK, USA). This cell line was previously
validated by this group [11] through real-time quantitative polymerase chain reaction (rt-
qPCR) analysis for cone specific opsins; blue cone opsin (Opn1sw) and red/green opsin
(Opn1mw). Cells were cultured in Dulbecco’s Modified Eagle’s medium (DMEM) (Sigma)
supplemented with 10% fetal calf serum (FCS) and 1% penicillin streptomycin (PS) and main-
tained at 37°C in a humidified 5% CO2 atmosphere. To analyze the effects of Norgestrel
(Sigma) on 661W cells, cells were seeded in to the appropriate culture vessel and allowed to
attach overnight. Cells were then washed three times with warmed 1xPBS and complete or
serum-freemedium supplemented with 20 μMNorgestrel or DMSO vehicle (Sigma) added.
After incubation for the indicated times, cells were detached using accutase (Sigma) and,
together with their supernatant, centrifuged and washed with 1x PBS to leave a whole cell
pellet.
Western Blotting
Whole retinas were lysed in RIPA buffer (Thermo) containing protease inhibitors (Thermo).
Lysates were centrifuged at 10,000 rpm at 4°C for 30 min. Supernatant was stored at -80°C.
Protein concentration was measured using a Bradford assay (Bio-Rad,Hercules, US). 4–15%
gradient gels (Bio-Rad) were used for SDS-PAGE and proteins were then transferred to a nitro-
cellulosemembrane. 30μg of protein was loaded per sample. Total protein levels are an accu-
rate way of verifying equal loading [26] and so were analyzed using REVERT total protein
stain (LiCor, Lincoln, US) as per manufacturer’s instructions and imaged on a LiCor scanner
in the 700 channel. Membranes were blocked using Odyssey blocking buffer (LiCor) for 30
min and probed with fractalkineprimary antibody (Abcam, Cambridge, UK) in blocking
buffer and 0.1% Tween 20 for 4 nights at 4°C.Membranes were washed using TBS-T and
probed with rabbit 800 secondary antibody (LiCor).Membranes were washed using TBS and
imaged on a LiCor scanner.
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Nitrite parameter assay
Cell culture media from rd10 primarymicroglia treated with 20 μMNorgestrel or DMSO over
24 hr was collected.Media was centrifuged at 1000 rpm for 5 min to remove particulates.
Supernatant was stored at -20°C. Samples were analyzed for endogenous nitrite (R&D systems,
Minneapolis, US) according to manufacturer’s instructions.
Culture of primary microglial cells
A protocol for isolating and culturing retinal microglia was adapted from a previously pub-
lished protocol [27]. Briefly, retinas were dissected from the eyes of P16 rd10 mice, ensuring
minimum contamination with vitreous body and retinal pigment epithelium. Four retinas
were pooled, cut into small pieces and incubated for 40 min at 37°C in 1 ml 1xPBS with 1 mg/
ml collagenase type I (Sigma), 0.3 mg/ml DNase I (Roche, Basel, Switzerland), and 0.2 mg/ml
hyaluronidase (Sigma). The cell suspension was filtered through a 70-μm cell strainer (Becton
Dickinson, Franklin Lakes, US). Cells were washed twice with 10 ml DMEM/10% FCS/1% PS
and resuspended in 15ml DMEM/10% FCS/1% PS. To isolate the mononuclear cells, the sus-
pension was gently added to 15ml Ficoll paque premium reagent (GE Life Sciences, Bucking-
hamshire, UK) and centrifuged for 20 min at 2000 rpm without the brake in a BeckmannGS-
6R centrifuge. The interphase was removed carefully and washed twice with 10 ml DMEM/
10% FCS/1% PS. The cells were cultured for 3 days, on either polylysine-coated coverslips in 24
well plates or T25 cm2 flasks containing DMEM/10% FCS/1% PS. Culture purity was con-
firmed by the absence of retinal astrocytes,Müller glia, rods, retinal ganglion, amacrine, hori-
zontal and bipolar cells, as assessed by immunofluorescence (S2 Fig). Although rare, some
debris from these cell types was found in culture (S2A Fig, inserts), however all Hoechst-posi-
tive cells stained positively for ionized calcium-binding adaptor molecule 1 (Iba1) and so were
confirmed to be microglia (S2B Fig). P16 was chosen as the time-point to harvest primary cells.
Microglia respond and migrate to the mutated photoreceptors becoming activated by P15 in
the rd10 retina compared to C57 control [9]. This time-point therefore represents a time when
microglia have responded to the mutated photoreceptors but photoreceptor cell death has not
yet taken place. This eliminates the response of microglia to accumulating photoreceptor cell
debris.
Culture of 661W cells in microglial-conditioned media
A total of six retinas from three P16 rd10 mice were used to make the primary culture for the
conditionedmedia experiment. Primarymicroglia were cultured in T25cm2 flasks for 2 days
before treating with Norgestrel or vehicle (DMSO). Cells were exposed to 20 μM Norgestrel in
DMSO or vehicle and left for 24 h. Cells were washed with 1xPBS and cultured in fresh
DMEM/10% FCS/1% PS for a further 24 h. This conditionedmedia was collected and added to
661W cells. 661W cells were seeded overnight in 96 well plates (Sarstedt, Numbrecht, Ger-
many) to allow for cell adherence. All cells were then washed three times in 1xPBS and media
replaced with either basal microglialmedia, or conditionedmedia from treated primarymicro-
glial cells (100μl/well). Cells were incubated for 20 h before addition of MTS (3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)
for a further 4 h.
Co-culture of rd10 microglia with 661W cells
A total of sixteen retinas from eight P16 rd10 mice were used to make the primary culture for
the co-culture experiment with 661W cells following treatment with Norgestrel. Primary
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microglia were cultured on polylysine-coated coverslips in 24 well plates for 1 day before treat-
ing with Norgestrel or vehicle (DMSO). Primary cells were exposed to 20 μM Norgestrel or
vehicle and left for 24 h. Cells were washed with 1xPBS prior to the addition of healthy or
serum-starved661W cells that had been treated with Norgestrel or vehicle in the preceeding 3
h. 661W cells suspended in fresh DMEM/10% FCS/1% PS were added to the microglia at a
density of 25 x 103 per well. Co-cultures of microglia and 661W cells were left for 24 h before
fixation in 4% PFA.
A total of eighteen retinas from nine P16 rd10 mice were used to make the primary culture
for the co-culture experiment with 661W cells following treatment with recombinant fractalk-
ine. Primarymicroglia were cultured on polylysine-coated coverslips in 24 well plates for 1 day
before treating with recombinant mouse full-length fractalkine (R&D systems cat. no. 472-FF-
025) or vehicle (0.1% BSA in 1xPBS). Primary cells were exposed to 1.2μg/ml fractalkine or
vehicle and left for 24 h. Cells were washed with 1xPBS prior to the addition of serum-starved
661W cells. 661W cells suspended in fresh DMEM/10% FCS/1% PS were added to the micro-
glia at a density of 25 x 103 per well. Co-cultures of microglia and 661W cells were left for 24 h
before fixation in 4% PFA.
Quantification from immunohistochemically-labeled sections and cells
Quantification of outer nuclear layer (ONL) thickness and outer segment length in retinal sec-
tions was carried out using ImageJ software. Average ONL thickness was measured by taking
measurements from at least 20 sections per mouse. Per section, three distinct measurements
were taken and averaged. Average outer segment length was measured by takingmeasurements
from at least four sections per mouse. Per section, three distinct measurements of rod or cone
outer segment length were taken and averaged. Three mice were analyzed per group. Fluores-
cence intensity measurements of CD68, iNOS andMRC1 in primarymicroglia were performed
using ImageJ software, by measuring points of intensity within single cells.
Assessment of cell viability in 661W cells by the MTS assay
Cells seeded overnight (2 x 103 per well 96 well plate) were washed three times in 1xPBS before
treatment (conditionedmicroglialmedia). After 20 h of treatment incubation, 20μl of MTS
solution (Promega) was added to each well and incubated for a further 4 h at 37°C. Viable cells
in the presence of phenazine methosulfate (PMS) will reduce the MTS solution to form forma-
zan. Detection and quantification of the formazan crystals was carried out with a microplate
reader (Molecular Device Corporation, Sunnyvale, US) at 490nm. 490nm readings taken from
non-template wells (media and MTS, without cells) were deducted from actual cellular read-
ings. A further reading at 650nm was taken from all wells and deducted from the 490nm read-
ings to account for any cellular debris. The quantity of formazan product as measured by the
amount of 490nm absorbance is directly proportional to the number of living cells in culture.
Therefore the absorbance of the formazan formed in ‘control cell wells’ was taken as 100%
viability.
Total RNA Isolation and quantitative real-time polymerase chain
reaction (rt-qPCR)
Total RNA was isolated from whole 661W cells and RNA-later (Qiagen, Hilden, Germany)
protected tissue using RNeasy Mini Kit (Qiagen), or from primarymicroglia using RNeasy
Micro Kit (Qiagen) followingmanufacturer’s protocol. Genomic DNA was eliminated in
661W cells/tissue samples using RNase free DNase (Qiagen) and in primarymicroglia using
gDNA eliminator columns (Qiagen) and cDNA was subsequently synthesized using
Inflammation and Fractalkine in the Degenerating Mouse Retina
PLOS ONE | DOI:10.1371/journal.pone.0165197 November 4, 2016 7 / 27
QuantiTect Reverse Transcription Kit (Qiagen). Rt-qPCR was performed using QuantiTect
SYBR Green PCR Kit (Qiagen) and 10ng cDNA/well of a 384 well plate (Starstedt AG & Co.)
for 661W cells/tissue and 5ng cDNA/well for primarymicroglia. Plates were run using the
Applied Biosystems 7900HT Fast Real-Time PCR System (Life Technologies Ltd., Carlsbad,
US) and each set of reactions included both a non-reverse transcription control and a no tem-
plate sample negative control (data not shown). The protocol consisted of a cycling profile of
30s at 95°C, 60s at 60°C, and 30s at 72°C for 40 cycles. Qiagen QuantiTect Primer assays were
used for all genes (Table 2). Melt curve analysis confirmed single PCR product. Relative
changes in gene expression were quantified using the comparative Ct (ΔCt, ΔΔCt) method as
describedby Livak & Schmittgen [28, 29]. The Ct value of the gene of interest was normalized
to an average of three endogenous housekeeping genes (Actb, Gapdh and Hprt). This was com-
pared to the normalized control sample–an aged matched control diet rd10 value, representa-
tive of all control samples (N = 3) or an equivalent DMSO control (661W cell treatments).
Alteration in mRNA expression of genes was defined as fold difference in the expression level
in cells/tissue after treatment, relative to that of the control. This is the standard method for
presenting rt-qPCR data [28, 29].
Statistical analysis
Values in all graphs represent the mean ± standard error of the mean (SEM) and are represen-
tative of at least three individual experiments repeated in triplicate. Data were statistically ana-
lyzed using Student t-test and two-way ANOVA (Graph Pad, Prism 6) with values of p< 0.05
being considered statistically significant. Values that were more than ± 3 standard deviations
Table 2. List of Qiagen Quantitect Primer assays used in RT-qPCR.
Gene Qiagen Primer Product Size RefSeq ID#
Actin QT00095242 149 NM_007393
GAPDH QT01658692 144 NM_008084
HPRT QT00166768 168 NM_013556
PR A/B QT00114534 118 NM_008829
PGRMC1 QT00250887 131 NM_016783
PGRMC2 QT00258608 111 NM_027558
mPRα QT00138145 78 NM_027995
mPRβ QT00123886 67 NM_028829
mPRγ QT01067612 67 NM_028748
iNOS QT01547980 131 XM_001004823
Arginase QT00134288 109 NM_007482
Mannose Receptor QT00103012 132 NM_008625
HMGB1 QT00247786 78 NM_010439
IL-1α QT00113505 110 NM_010439
MIP1Alpha QT00248199 107 NM_011337
MIP1Beta QT00154616 110 NM_013652
MCP1 QT00167832 118 NM_011333
MCP3 QT00171458 117 NM_013654
Fractalkine QT00128345 98 NM_009142
CX3CR1 QT00259126 63 NM_009987
IL-1β QT01048355 150 NM_008361
IL-6 QT00098875 128 NM_031168
TNF-α QT00104006 112 NM_013693
doi:10.1371/journal.pone.0165197.t002
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from the mean were classed as outliers and removed from analysis. A multi-factor analysis of
variance (MANOVA) was used to evaluate the effects of treatment (control vs. Norgestrel-sup-
plemented diet), age and light intensity, on ERG responses. For ERG results, when a 0.05 level
of significancewas observed, post-hoc pairwise comparisons using Bonferroni's test were car-
ried out.
Results
Norgestrel-supplemented diet from P10 results in significant protection
of photoreceptors in the rd10 mouse
Norgestrel has previously been shown to provide significant neuroprotection to the rd10 retina
when administered by intra-peritoneal injection from P18 [10]. We sought to evaluate the pro-
tection offered by Norgestrel when using a less invasive method of diet-supplementation.We
also recognized a need to administer Norgestrel at an earlier age based on recent findings that
the rd10 retina displays significant abnormalities prior to photoreceptor cell loss [9]. Dams of
newborn rd10s were given a Norgestrel-supplemented diet when their pups reached post-natal
day 10 (P10), and all rd10s continued to receive a Norgestrel-supplemented diet post-weaning.
Control rd10 litters received an identical diet without Norgestrel. Norgestrel-supplemented
rd10’s demonstrated lower levels of TUNEL positivity in the central outer nuclear layer (ONL)
at P15 and P20 compared to control (Fig 1A), coinciding with significant preservation of pho-
toreceptors. As expected, control rd10 mice revealed a substantial loss of photoreceptors
between P15 and P25 (Fig 1 & S1 Fig) [9]. At P20, ONL thickness in the Norgestrel-fed rd10
mice was comparable to age-matched C57 retina (S1 Fig). Measurement of ONL thickness con-
firmed significant Norgestrel-induced ONL protection out to P40 in both the central and
peripheral retina (Fig 1B). Norgestrel’s neuroprotective effects were lost by P50.
Norgestrel-supplemented diet results in significant functional
preservation in the rd10 retina
In order to determine functionality of the rd10 retina following Norgestrel-diet supplementa-
tion, scotopic electroretinogram(ERG) recordings were taken in mice at P20 and P31, where
significant preservation of the ONL was observed (Fig 1). ERG results confirmed functional
preservation of the rd10 retina (Fig 2A). As previously described [5, 6], the amplitudes of the a-
and b-waves in rd10 mice at P20 were diminished compared to age-matched wild type animals.
This decline was significantly attenuated by Norgestrel diet supplementation (Fig 2B). Remark-
ably, the protective effect of Norgestrel on a- and b-wave amplitudes persisted at P31, where
the values corresponding to the b-wave amplitudes were even higher than those of P20 mice
fed with control diet.
Norgestrel-supplemented diet results in significant preservation of
photoreceptor outer segments in the rd10 mouse
In order to assess preservation of photoreceptor outer segments with Norgestrel diet, markers
for rod (rhodopsin; red) and cone (PNA; green) outer segments were used on retinal sections.
Outer segments were longer and denser in the central retina of Norgestrel treated mice com-
pared to control (Fig 3A and 3B). This morphological change was observed from P15 for rods
and from P20 for cones in the central retina (Fig 3A and 3B). Quantification of rod and cone
outer segment length confirmed significant preservation out to P25 (Fig 3C).
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Microglial response in the rd10 retina is significantly altered with
Norgestrel treatment
Previous studies have highlighted a role for microglia in potentiating photoreceptor cell death
in the rd10 mouse by driving inflammatory processes [18, 19]. We therefore sought to study
microglial dynamics in rd10 mice following administration of Norgestrel. Amoeboidmicroglia
(ionized calcium-binding adapter molecule 1; Iba1) were observed surrounding the ONL (Fig
4A), during the peak of cell death (P15 and P20) in the control retina as previously reported [9,
18]. Some stained positively for cluster of differentiation 68 (CD68), a marker used to identify
phagocytic, activated microglia [30]. Conversely, microglia were ramified in morphology in
Norgestrel-fed mice (P15, P20) and showed less CD68 immunoreactivity than control (Fig
4A). Norgestrel-diet significantly reducedmicroglial number at P15 and P20 (Fig 4B) and
Fig 1. Norgestrel-supplemented diet significantly protects against photoreceptor cell death out to P40 in the rd10 retina. (A)
Apoptosis of retinal cells was detected by terminal dUTP nick end-labeling (TUNEL; green & greyscale) of DNA strand breaks in cell nuclei.
Norgestrel treatment (NORG diet) decreased TUNEL-positive staining in the central P15 and P20 retina compared to control mice (Control
diet). N = 3 mice per group. Hoechst (blue) staining reveals the cell layers in the retina. Scale bar 50μm. (B) Quantification of outer nuclear
layer (ONL) thickness in the central and peripheral retina. N = 3 mice per group, n = 20 sections per mouse. Results are presented as
mean ± SEM (t-test, *p<0.05, **p<0.01, ***p<0.005).
doi:10.1371/journal.pone.0165197.g001
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Fig 2. Norgestrel-supplemented diet significantly preserves retinal function in the rd10 retina. (A)
Representative scotopic ERG waveforms performed on (i) P20 and (ii) P30-31 rd10 mice on a control or
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CD68-positivity at P20 (Fig 4C). The apparent correlation between significant photoreceptor
protection and less microglial activation in Norgestrel-fed animals (Fig 4A–4C), implicates
microglia in the cell death observed in rd10 mice. Inducible nitric oxide synthase (iNOS) is a
marker used to identifyM1 microglia in the rodent retina [31]. Markers of anti-inflammatory
Norgestrel-supplemented diet or C57 mice indicating increased neurotransmission in Norgestrel-fed rd10 mice at
both time-points. (B) Light intensity-response curves of (i) P20 and (ii) P31 rd10 mice on a control (circles) or
Norgestrel-supplemented diet (squares), showing statistically significant differences between treatments, in both
a- and b-wave amplitudes. N = 4 mice per group, n = 3–10 recordings per mouse. Results are presented as
mean ± SEM (MANOVA, Bonferroni post-hoc test, *p<0.05, **p<0.001).
doi:10.1371/journal.pone.0165197.g002
Fig 3. Norgestrel preserves rod and cone outer segment morphology in the rd10 retina. Confocal microscopic images of (A) rod
(rhodopsin; red) and (B) cone outer segments (PNA; green) in the central retina from P15-P40 of control and Norgestrel-fed rd10 mice.
Outer segments are shorter and sparser in the control diet retina from P15 for rods (A) and from P20 for cones (B). N = 3 mice per group.
Hoechst (blue) staining reveals the cell layers in the retina. Scale bar 50μm. (C) Quantification of rod and cone outer segment thickness in
the central retina in control vs. Norgestrel-fed rd10 mice. N = 3 mice per group, n = 8 sections per mouse. Results are presented as
mean ± SEM (t-test, *p<0.05, ****p<0.0001).
doi:10.1371/journal.pone.0165197.g003
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Fig 4. Norgestrel dampens pro-inflammatory microglial activity in vivo and decreases DAMP release from photoreceptors. (A)
Confocal microscopic images of microglia (Iba1; red) and activated microglia (CD68; green) in the central retina from P15-P25 control and
Norgestrel-fed rd10 mice. Less microglia including CD68+ microglia were observed at P15 and P20 in Norgestrel-fed mice. Hoechst (blue)
staining reveals the cell layers in the retina. Scale bar 50μm. N = 3 mice per group, n = 8 sections per mouse. (B & C) Quantification of
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microglia (M2) have also been characterized, including mannose receptor C, type 1 (CD206/
MRC1) [32] and arginase [30]. mRNA analysis on whole retina confirmed a Norgestrel-driven,
significant decrease in iNOS expression (M1) at P20 and P25, and an increase in MRC1 (M2)
at P20 and arginase (M2) expression at P25 and P30 (Fig 4D). High mobility group box 1 pro-
tein (HMGB1) and interleukin 1α (IL-1α) belong to the family of danger-associatedmolecular
pattern molecules (DAMPs), expressed and released by damaged cells to trigger inflammation
[33–36]. mRNA analysis of DAMP expression showed that Norgestrel induced a significant
decrease in HMBG1 and IL-1α at P20 and P25 (Fig 4E), coinciding with increased photorecep-
tor survival (Fig 1), less M1 and increasedM2 microglial activation (Fig 4A–4D).
Norgestrel significantly reduces rd10 microglial-driven, cell contact-
dependent degeneration of 661W cells
In order to evaluate the contribution of microglia to the course of photoreceptor cell loss in the
rd10 retina in more detail, we utilized primary cell cultures of P16 rd10 retinal microglia. Cul-
ture purity was confirmed (S2 Fig). Due to the difficulty in isolating pure photoreceptor pri-
mary cultures and in order to assess the interaction betweenmicroglia and photoreceptors, we
utilized the cone photoreceptor-like 661W cell line. Our group has previously used 661Ws as
an in vitromodel to study how photoreceptors respond to stressful stimuli and to understand
how Norgestrel works in providing neuroprotection [11–13].
To determine the effects of released factors from rd10 microglia on 661W viability, healthy
661Ws were cultured for 24 h with conditionedmedium (CM) from rd10 microglia pre-treated
with 20 μMNorgestrel or equivalent DMSO control. 661W cell viability was then assessed
using the MTS assay. Whilst CM from DMSO-treated microglia resulted in a ~14% increase in
661W cell death, CM fromNorgestrel-treated microglia resulted in only a ~4% increase com-
pared to untreated control (Fig 5A). This suggests a novel role for Norgestrel in modulating
microglial responses in the rd10 retina.
We hypothesized that direct cell-cell contact may regulate microglial responses [37, 38], for
in the early stages of rd10 retinal degeneration, microglia associate closely with cells in the
ONL [9, 18]. Therefore, a co-culture assay was designed using a combination of rd10 microglia,
healthy 661Ws and serum-starved661Ws. This enabled us to analyze the direct effects of Nor-
gestrel on microglia and photoreceptors in a way that more closely resembled the in vivo state.
Prior to co-culture, primary rd10 microglia and 661W cells were treated with 20 μM Norgestrel
or equivalent DMSO control (24 h microglia, 3 h for 661Ws). 661W cells were then added to
the microglia and incubated for a further 24 h. During this time, microglia appeared to migrate
and settle in clusters close to 661W cells (Fig 5B). Subsequent cell viability of co-cultured
661W cells was assessed using the TUNEL assay.
After 24h of co-culture, ~32% of healthy 661W cells cultured with microglia were TUNEL
positive compared to ~1.8% of 661W cells cultured in isolation (Fig 5D (i) and 5E (i)). This
strongly suggests that direct rd10 microglia-661W cell contact will result in higher levels of cell
microglial number and CD68-positivity confirmed (B) significantly less microglia at P15 and P20 and (C) significantly less CD68-positivity at
P20 with Norgestrel-supplementation. (D) RT-qPCR analysis of mRNA encoding (i) pro-inflammatory (M1) and (ii) & (iii) anti-inflammatory
(M2) microglial markers in whole retina from P20-P30 control and Norgestrel-fed rd10 mice. Norgestrel significantly reduced pro-
inflammatory and increased anti-inflammatory markers in the retina. Control column represents age-matched rd10 mice on control diet.
N = 3 mice per group, n = 3 technical replicates per mouse. (E) RT-qPCR analysis of mRNA encoding danger associated molecular patterns
(DAMP), (i) high motility box group 1 (HMGB1) and (ii) interleukin-1α (IL-1α) in whole retina from P20-P30 control and Norgestrel-fed rd10
mice. Norgestrel significantly reduced DAMP expression at P20 and P25 in Norgestrel-fed mice. Control column represents age-matched
rd10 mice on control diet. N = 3 mice per group, n = 3 technical replicates per mouse. Results are presented as mean ± SEM (t-test, *p<0.05,
***p<0.005, ****p<0.0001).
doi:10.1371/journal.pone.0165197.g004
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Fig 5. Norgestrel significantly abrogates rd10 microglial-induced 661W cell death. (A) Conditioned media was collected from primary
microglial cells cultured with (CM + NORG), or without (CM) 20 μM Norgestrel over 24 h. 661W cells were cultured over a further 24h in the
absence (Control) or presence of conditioned media (CM, CM + NORG) and percentage cell death was assessed by the MTS assay.
Exposing 661Ws to CM from rd10 microglia resulted in increased neuronal cell death whereas pre-treatment of rd10 microglia with
Norgestrel significantly reduced cell death. N = 6 biological replicates, n = 4 technical replicates per group. (One way ANOVA followed by
Tukey’s post-hoc test,). (B) Representative fluorescent microscopic image of primary rd10 microglial cells (Iba1; red) in culture with 661W
cells (Cone arrestin; green). Hoechst (blue) staining reveals cell nuclei. Scale bar 30μm. (C) 661W cells were cultured in the presence of
C57 or rd10 primary retinal microglia. Apoptosis of 661W cells as detected by TUNEL of DNA strand breaks in cell nuclei revealed
significantly more 661W cell death when cultured with rd10 microglia. (D) 661W cells were cultured in (i) the presence of (healthy 661W) or
(ii) absence of (serum-starved 661W) serum over 3 h. These cells were simultaneously treated with either 20 μM Norgestrel (661W NORG)
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death, than when 661W cells are exposed to secretedmicroglial factors alone (compare Fig 5A
to 5E (i)). Retinal microglia from age-matched C57 mice treated identically to rd10 microglia
resulted in 2.1% 661W cell death (Fig 5C), confirming that rd10 microglia specifically drive
neuronal cell death.
The previous experiment was replicated using serum-starved661W cells, a previously estab-
lishedmethod for inducing 661W cellular stress [11, 13]. This allowed us to investigate the
response of microglia to damaged photoreceptors, in an attempt to mimic photoreceptor stress
present in the rd10 mouse retina. 661Ws were serum-starved for 3 h, resulting in ~8% cell
death as assessed by TUNEL (Fig 5E (ii)). Addition of rd10 primarymicroglial cells for 24 h
increased 661W cell death to ~50%, a 42% increase in cell death compared to serum-starved
661W cells cultured in isolation (Fig 5D (ii) and 5E (ii)).
Treatment of rd10 microglia with 20 μMNorgestrel prior to co-culture significantly reduced
their ability to damage healthy and serum-starved661W cells (Fig 5E (i) (ii)), indicating that
Norgestrel can work directly on microglia. Interestingly, pre-treatment of 661W cells with
20 μMNorgestrel also resulted in increased 661W protection (Fig 5E (i) (ii)), demonstrating
Norgestrel’s ability to prime undamaged and stressed photoreceptors against microglial-
derived harmful stimuli.
Norgestrel modulates pro- and anti-inflammatory states in rd10
microglia
Norgestrel can act directly on rd10 microglia and consequently prevent microglial-driven661W
cell death (Fig 5). Norgestrel mediates its neuroprotective effects through progesterone receptors
[11]. mRNA analysis revealed similar expression patterns of progesterone receptor membrane
complexes 1 and 2 (PGRMC1, PGRMC2), and membrane progesterone receptors α, β and γ
(mPRα, β, γ) in rd10 microglia (Fig 6A). Immunofluorescence confirmed expression of these
receptors (Fig 6B). Classical progesterone receptors A and B (PRA/B) were not detected in these
cells (Fig 6A and 6B). Primary rd10 microglia were subsequently treated with 20 μMNorgestrel
and analyzed by immunofluorescence for M1 and M2 state markers. Norgestrel induced signifi-
cantly lower levels of CD68 and iNOS (M1) and higher levels of MRC1 (M2) in rd10 microglia
compared to control (Fig 6C). Nitric oxide production was assessed indirectly by measuring
endogenous nitrite levels in media from primary rd10 microglia treated with Norgestrel or vehi-
cle. Norgestrel significantly lessened endogenousmicroglial nitrites (Fig 6E). Thus, we hypothe-
size that Norgestrel dampens pro-inflammatory activity and stimulates anti-inflammatory states
in rd10 microglia, resulting in increased protection of photoreceptors.
Norgestrel acts as an anti-inflammatory in stressed 661W cells and in
rd10 mice
Microglial infiltration and phenotypic activation is driven by differential chemokine signaling
[39, 40]. Several cytokines and chemokines includingMIP-1α (CCL3),MIP-1β (CCL4),MCP-
1 (CCL2),MCP-3 (CCL7), TNF-α, IL-1β and IL-6 have been implicated in photoreceptor-
or vehicle control (661W). The treated 661W cells were then placed in culture with microglia that had been treated with (Microglia NORG) or
without (Microglia) 20 μM Norgestrel over 24h. Co-cultures were incubated for a further 24h. Apoptosis of 661W cells was detected by
TUNEL of DNA strand breaks in cell nuclei. All Norgestrel-treated co-cultures had significantly less TUNEL-positive 661W cells than
equivalent vehicle controls. Hoechst (blue) staining reveals the cell nuclei. Scale bars 50μm. (E) Quantification of TUNEL-positive 661W
cells cultured in (i) the presence of (healthy 661W) or (ii) the absence of (serum-starved 661W) serum and following Norgestrel or vehicle
DMSO treatment and co-incubation with primary rd10 microglial cells pre-treated with Norgestrel or vehicle DMSO. N = 8 mice for primary
culture, n = 6 technical replicates per group. Results are presented as mean ± SEM (t-test, *p<0.05, **p<0.01, ***p<0.005,
****p<0.0001).
doi:10.1371/journal.pone.0165197.g005
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Fig 6. Norgestrel reduces pro-inflammatory and promotes anti-inflammatory phenotypes in rd10 microglia. (A) RT-qPCR analysis
detected similar levels of mRNAs encoding progesterone receptor membrane complexes 1 and 2 (PGRMC1, PGRMC2) and all three
membrane progesterone receptor isoforms, α, β and γ (mPRα, mPRβ, mPRγ) in rd10 retinal microglial cells. Classical progesterone
receptor (PR A/B) was not expressed. Actin, HPRT and GAPDH served as reference genes. (B) Immunolabeling confirmed the presence of
these progesterone receptors in primary rd10 microglial cells. Hoechst (blue) staining reveals the cell nuclei. Scale bar represents 10μm.
(C) Fluorescent microscopic images of primary rd10 microglia immunolabeled for (C) (i) markers of activation (CD68) and pro-inflammation
(M1) (iNOS) and (C) (ii) anti-inflammatory activation (M2) (MRC1); after treatment with 20 μM Norgestrel over 24h. Norgestrel reduced pro-
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microglial crosstalk and retinal degeneration [18, 31, 41–45]. Thus we sought to elucidate how
Norgestrel treatment affected expression of these cytokines and chemokines. Both in stressed
661W cells (Fig 7A) and during the early stages (P15 –P20) of rd10 disease progression (Fig
7B), Norgestrel successfully acts as an anti-inflammatory agent, downregulating cytokine gene
expression. This downregulation is concurrent with reduced gene transcription of pro-inflam-
matory mediators TNFα, IL-1β and IL-6 (Fig 7C). Secreted from retinal microglia, these cyto-
kines likely act on photoreceptors to potentiate cell death [18, 46–48]. A loss of photoreceptors
at P25 correlates with an upregulation of chemokine and cytokine gene expression (Fig 7B and
7C) and infiltration of microglia to the ONL (Fig 4A).
Norgestrel upregulates neuroprotective fractalkine-CX3CR1 signaling in
the rd10 retina
Fractalkine (CX3CL1) is a chemokine synthesized as a 50-75kDa protein [49]. It is glycosylated
forming a 100kDa isoform, which is membrane-bound [49–51]. Full-length fractalkine consists
of a chemokine domain with CX3Cmotif, highly-glycosylatedmucin-like stalk, a transmem-
brane domain and a short cytoplasmic domain [52]. Membrane-bound fractalkine is cleaved by
metalloproteinases, such as ADAM10, to release soluble fractalkine (85kDa) [53]. Fractalkine is
also recycled from the membrane and stored in intracellular vesicles [51, 54], possibly as a 95kDa
isoform [50]. Signaling to its receptor CX3CR1 onmicroglia [55], both in vivo and in vitro studies
have shown that complementary fractalkine-CX3CR1signaling can modulate microglial activa-
tion and migration resulting in improved neuronal survival [56–61]. Therefore, we explored Nor-
gestrel’s ability to upregulate fractalkine and CX3CR1 gene expression, in the degenerating rd10
retina. Norgestrel treatment of stressed 661W cells significantly upregulated fractalkinemRNA
over 24 h (Fig 8A). In the rd10 retina, Norgestrel significantly increased fractalkine levels at P20
by over 1000-fold that of the control (Fig 8B); coincidingwith significant protection of the ONL
(Fig 1). Norgestrel also significantly upregulated CX3CR1 gene expression (Fig 8B). Norgestrel-
induced fractalkine signalingwas dampened at later time points (P25, P30) compared to P20 (Fig
8B) correlating with photoreceptor loss in Norgestrel-treated mice (Fig 1). Western blotting
revealed an increase in 100kDa fractalkineprotein at P20 and P25 with Norgestrel (Fig 8C; red
boxes). This isoform is neuroprotective in the retina by dampening harmfulmicroglial processes
and consequently improving photoreceptor survival [57, 62]. Immunofluorescence on retinal
sections also showed an increase in fractalkinewith Norgestrel (Fig 8D). Fractalkinewas found
predominantly in the ONL and outer plexiform layer (OPL), and staining was increased in all
(P15-P40) Norgestrel-fed mice compared to control (Fig 8D). Primary rd10 microglia treated
with recombinant full-length fractalkine for 24 h and subsequently co-culturedwith serum-
starved 661W cells induced significantly less 661W cell death compared to vehicle (Fig 8E and
8F). This suggests that Norgestrel drives an upregulation of fractalkine in the retina, which will
reducemicroglial-drivenneuronal cell death.
Discussion
In this study we demonstrate the protective properties of the synthetic progestin ‘Norgestrel’,
when administered via non-invasive diet supplementation. Previously shown to protect
inflammatory and increased anti-inflammatory markers in rd10 microglia. Scale bar 10μm. (D) Quantification of fluorescence intensity of (D)
(i) CD68 and iNOS and (D) (ii) MRC1 in primary rd10 microglial cultures following Norgestrel treatment over 24h. N = 8 mice, n = 4 technical
replicates per group. (E) Nitrite concentration in the media of rd10 microglia in vitro treated with Norgestrel or vehicle over 24hr. Norgestrel
significantly reduced nitrite release from rd10 microglia. N = 8 biological replicates, n = 2 technical replicates per sample. Results are
presented as mean ± SEM (t-test, *p<0.05, ***p<0.005, ****p<0.001).
doi:10.1371/journal.pone.0165197.g006
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through an upregulation of growth factors [12, 13], this study highlights a novel role for Nor-
gestrel, in acting directly upon microglial cells to dampen damaging inflammatory processes.
This is an important finding as recent literature has shown that microglial cells may potentiate
retinal disease [18, 19, 21, 44, 63, 64]. We also provide furthermechanistic insight, showing
that Norgestrel drives up fractalkine expression in the rd10 retina, which likely acts to further
dampen microglial activation.
Our group has previously shown that Norgestrel is neuroprotective in the rd10 retina when
administered via intraperitoneal injection from P18 [10]. Since this study, we have demon-
strated that significantmorphological changes take place in the rd10 retina prior to photore-
ceptor cell loss [9]. In light of this finding, we sought to administer Norgestrel from an earlier
time-point.We also wished to use a less invasive method and avoid the use of the vehicle
DMSO, which has been shown to significantly affect cell metabolism in several ways including
acting as an anti-inflammatory [65]. Using a supplemented-diet from P10, we have demon-
strated increased protection with Norgestrel in the rd10 retina (Fig 1) compared to intra-peri-
toneal injection from P18 [10].
We hypothesized that rd10 retinal microglia drive targeted neuronal degeneration of viable
cells in a cell autonomous manner. In order to substantiate this claim, and subsequently inves-
tigate the direct effects of Norgestrel on microglia, we utilized in vitro cultures of 661W cone
photoreceptor-like cells and primary rd10 microglia both in isolation and in co-culture. By cul-
turing 661Ws with Norgestrel-treated rd10 microglial conditionedmedia, we show that Nor-
gestrel dampens damaging inflammatory factor secretion (Fig 5A). Interestingly, direct
microglia-photoreceptor contact induces significantlymore cell death of healthy 661Ws than
conditionedmedia alone (compare Fig 5A to 5E (i)). Extrapolating this to the in vivo situation,
this suggests that microglia can cause higher levels of cell death when they have reached the
ONL and are in direct contact with photoreceptors. These results also confirm our hypothesis,
showing that isolated rd10 microglia drive targeted cell death of healthy photoreceptors, as pri-
mary C57 microglia did not induce 661W cell death. Inducing ~30% and ~42% cell death in
healthy and serum-starved661W cells respectively, 661W cells are more vulnerable to damag-
ing microglial-contactwhen already stressed (compare Fig 5D (i) to 5D (ii)). Importantly, Nor-
gestrel alleviates microglial-drivenneuronal death of healthy and stressed 661Ws, by acting
directly on both microglia and 661W cells. Of course, microglial-driven cell death is initiated
due to effects from the mutation in pde6b. Microglia are therefore stimulated to adopt a damag-
ing phenotype by signals from other cell types in the retina. However, once activated microglia
will likely promote further degeneration of viable photoreceptors, exacerbating disease
progression.
We suggest that Norgestrel works through progesterone receptors present on microglial
cells to reduce pro-inflammatoryM1 and stimulate anti-inflammatoryM2 phenotypes (Figs 4
& 6). Ultimately, these actions preserve photoreceptor cell viability. This finding was supported
Fig 7. Norgestrel reduces inflammation in 661Ws and the rd10 retina at P15 and P20. (A) 661W cells were
serum-starved and treated with 20μM Norgestrel or the equivalent DMSO control (Control) over 24h. RT-qPCR
analysis detected a significant decrease in mRNA levels of macrophage inflammatory protein 1α and 1β (MIP-1α,
MIP-1β), monocyte chemoattractant proteins 1 and 3 (MCP1, MCP3) and interleukin 6 (IL-6) in serum-starved
cells treated with Norgestrel. N = 6 biological replicates, n = 3 technical replicates per sample. (B-C) Retinal
cytokine mRNA levels were measured by RT-qPCR analysis, in P15-30 rd10 mice. Relative (B) chemokine (MIP-
1α, MIP-1β, MCP1 and MCP3) and (C) pro-inflammatory cytokine (tumour necrosis factor α (TNFα), interleukin
1β (IL-1β) and interleukin 6 (IL-6)) mRNA expression levels in retinas of rd10 mice supplemented with
Norgestrel. Control column represents age-matched rd10 mice on control diet. N = 3 mice per group, n = 3
technical replicates per mouse. Results are presented as mean ± SEM (t-test, *p<0.05, **p<0.01,
****p<0.001).
doi:10.1371/journal.pone.0165197.g007
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Fig 8. Norgestrel upregulates fractalkine-CX3CR1 signaling in the rd10 retina. (A) 661W cells were serum-starved and treated with
20 μM Norgestrel (Norgestrel) or the equivalent DMSO control (Control) over 6 and 24h. RT-qPCR analysis detected a significant increase
in mRNA levels of fractalkine in serum-starved cells treated with Norgestrel. N = 6 biological replicates, n = 3 technical replicates per
sample. (B) Norgestrel-supplementation in rd10 mice induced a significant increase in fractalkine and CX3CR1 mRNA expression in
P20-P30 retinas compared to control. Control column represents age-matched rd10 mice on control diet. N = 3 mice per group, n = 3
technical replicates per mouse. (C) Western blot for fractalkine at P20 and P25 confirmed an increase in full-length fractalkine (100kDa; red
box) at both time-points with Norgestrel treatment. Total protein stain shows similar loading between samples. Blots are representative of 6
biological replicates per group. (D) Fluorescent microscopic images of fractalkine (green) in the central retina from P15-40 of control and
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by rt-qPCR studies on whole retinas (Fig 7), whereby Norgestrel lead to a significant decrease
in pro-inflammatory TNFα and IL-1β gene expression, both expressed by retinal microglia
[66].
Norgestrel-diet administration prevented any photoreceptor loss between P15 and P20 in
rd10 mice (Fig 1 & S1 Fig).We believe this protection is largely owed to increased levels of Nor-
gestrel-induced fractalkine signaling. Norgestrel upregulated fractalkine expression by over
1000-times that of P20 control (Fig 8). Fractalkine signaling has been shown to prevent cell
loss in a number of different diseasemodels [56, 61, 67–70]. In mouse models of RP,
CX3CR1-/- rd10 mice experience a worsened disease progression [19] and intravitreal injection
of recombinant full-length fractalkine improves photoreceptor survival in the rd10 mouse [62].
Indeed we show that rd10 microglia pre-treated with full-length fractalkine cause significantly
less 661W cell death in co-culture (Fig 8E and 8F). These studies stand to corroborate the cru-
cial importance of fractalkine-CX3CR1signaling in retinal neuroprotection and the potential
of Norgestrel as a therapeutic for RP.
Of particular interest, full-length fractalkine appears to play a neuroprotective role by
dampening harmful microglial activity [57, 62], whereas soluble fractalkinemay potentiate dis-
ease progression by increasingmicroglialmigration [57]. In support of this, fractalkine cleav-
age increases prior to neuronal cell death in vitro [71] and loss of membrane-bound fractalkine
precedes degeneration in the rd10 retina [50]. Western blots of P20 retinas revealed an increase
in full-length (Fig 8C; 100kDa) and a decrease in soluble (Fig 8C; 85kDa) isoforms of fractalk-
ine with Norgestrel.
Ultimately however, Norgestrel’s neuroprotective effects are gradually lost from P25, though
Norgestrel-driven photoreceptor survival does not lapse entirely until P50 (Fig 1). It is worth
noting that the measurable neuroprotective effects observedwith Norgestrel are in line with
previous studies documenting other types of neuroprotective strategies in the rd10 retina [18,
19, 62]. Such studies similarly present therapeutic approaches resulting in delayed degeneration
rather than complete prevention of photoreceptor loss. This is likely due to the fact that the pri-
mary insult remains, the mutation in pde6b, and will therefore persist as a source of cellular
stress. Norgestrel-treated mice show a significant loss in fractalkine at the RNA and protein
level at P25 compared to P20 (Fig 8B–8D). Taken together with the bulk of evidence support-
ing fractalkine’s neuroprotective properties in the retina, we believe that loss of fractalkine sig-
naling is detrimental to photoreceptors. We hypothesize that such a loss in fractalkine
signaling at P25 contributes to microglial infiltration to the ONL (Fig 4A) and subsequent
potentiation of cell death (Fig 5).
In conclusion, this study outlines novel and desirable properties of the synthetic progestin
‘Norgestrel’, in acting directly on retinal microglia, and indirectly through photoreceptors, to
dampen damaging microglial activation in vitro and in vivo. The data presented suggest a criti-
cal role for Norgestrel-induced fractalkine signaling in the dampening of microglial activation.
Future studies will be aimed at further elucidating the role that fractalkine signaling plays in
retinal degeneration and Norgestrel-associated neuroprotection.We believe direct
Norgestrel-fed rd10 mice. Fractalkine staining is evident in the outer nuclear layer (ONL) of the retina in Norgestrel-supplemented mice.
Hoechst (blue) staining reveals the cell layers in the retina. Scale bar 50μm. N = 3 mice per group, n = 3 sections per mouse. (E) 661W cells
were cultured in the absence of serum (serum-starved 661W) over 3 h. 661W cells were then placed in culture with microglia that had been
treated with (Microglia Fract.) or without (Microglia) 1.2μg/ml recombinant full-length fractalkine over 24h. Co-cultures were incubated for a
further 24h. Apoptosis of 661W cells was detected by TUNEL of DNA strand breaks in cell nuclei. Co-cultures with fractalkine-treated
microglia had less TUNEL-positive 661W cells than equivalent vehicle control. Scale bar 30μm. (F) Quantification of TUNEL-positive 661W
cells cultured in the absence of serum and following co-incubation with primary rd10 microglial cells pre-treated with recombinant full-length
fractalkine or vehicle. N = 9 mice for primary culture, n = 5 technical replicates per group. Results are presented as mean ± SEM (t-test,
*p<0.05, ***p<0.005, ****p<0.001).
doi:10.1371/journal.pone.0165197.g008
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photoreceptor neuroprotection should remain at the forefront of RP immunotherapy develop-
ment: targeting mutated photoreceptors would alleviate subsequent photoreceptor-microglial
cell crosstalk, minimizing consequential microglial-drivenphotoreceptor cell loss. Additional
anti-inflammatory propertiesmay then further prevent microglial responses shown to exacer-
bate disease progression.
Supporting Information
S1 Fig. Representative images of retinal morphologyalong the verticalmeridian of the eye
of C57, rd10 control diet (rd10) and rd10 Norg diet (rd10 Norg) at P20. Retinal sections
were labelled with the nuclear stain, Hoechst, to demonstrate the loss of photoreceptors in the
rd10 retina (C57 vs rd10) and the neuroprotective effects of Norgestrel (rd10 vs rd10 Norg).
White boxes illustrate the regions used to image the central and peripheral retina. Scale bar
300μm.
(TIF)
S2 Fig. Characterizationof a pure microglial culture. (A & B) Fluorescent microscopic
images of primary rd10 microglial cells in vitro confirmed a pure microglial cell population.
Hoechst (blue) staining reveals the cell nuclei. (A)Antibodies targeted against astrocytes
(GFAP; red), Müller glial cells (glutamate synthase (GS); green), retinal ganglion cells (RGCs)
(neurofilament medium (NFM); green), amacrine cells (syntaxin 1; red), horizontal cells (cal-
bindin; red), bipolar cells (CEH10 homeodomain-containing homolog (CHX10); green) and
rods (rhodopsin (Rhod); red) showed no positive staining within the isolated population of
cells. Small quantities of non-nuclear (Hoechst negative) debris from these cells was found in
culture (see panel inserts). Scale bar 10μm. (B) Confocalmicroscopic XY image of primary
rd10 microglial cells in vitro (Iba1; red). Secondary only control (panel insert) confirmed spe-
cific staining of the antibody. Scale bar 10μm.
(TIF)
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